We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

95 hedge funds and large institutions have $177M invested in BioSpecifics Technologies Corp. in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

20% more capital invested

Capital invested by funds: $148M → $177M (+$29M)

10% more funds holding

Funds holding: 86 → 95 (+9)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
95
Holders Change
+9
Holders Change %
+10.47%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
37
Reduced
23
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$3.04M
2
OAM
Oxford Asset Management
United Kingdom
+$2.98M
3
RCMC
RK Capital Management (Colorado)
Colorado
+$2.9M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.06M
5
Wells Fargo
Wells Fargo
California
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$2.42M
2
Morgan Stanley
Morgan Stanley
New York
-$1.78M
3
BIT
BlackRock Institutional Trust
California
-$1.31M
4
PAI
Palo Alto Investors
California
-$1.27M
5
CCM
Cadence Capital Management
Massachusetts
-$913K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$2.36M +$552K +11,025 +25%
TCIM
27
TIAA CREF Investment Management
New York
$2M – – –
RA
28
Royce & Associates
New York
$1.99M – – –
Charles Schwab
29
Charles Schwab
California
$1.92M – – –
PI
30
Putnam Investments
Massachusetts
$1.5M -$41.6K -831 -2%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$1.49M -$85.6K -1,709 -5%
Goldman Sachs
32
Goldman Sachs
New York
$1.47M +$8.17K +163 +0.5%
American Century Companies
33
American Century Companies
Missouri
$1.43M +$15.4K +307 +0.9%
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.43M -$283K -5,647 -15%
First Manhattan
35
First Manhattan
New York
$1.16M – – –
BA
36
BlackRock Advisors
Delaware
$1.07M -$121K -2,421 -9%
BCM
37
Bridgeway Capital Management
Texas
$1.07M – – –
Prudential Financial
38
Prudential Financial
New Jersey
$1.07M -$316K -6,300 -20%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$1.04M -$15K -300 -1%
HIP
40
Hatteras Investment Partners
North Carolina
$977K +$1.14M +22,740 New
TCP
41
TAMRO Capital Partners
Virginia
$869K +$1.01M +20,229 New
TAM
42
Tocqueville Asset Management
New York
$859K – – –
GA
43
Geneva Advisors
Illinois
$739K -$134K -2,671 -13%
BIM
44
BlackRock Investment Management
Delaware
$738K +$1.9K +38 +0.2%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$721K – – –
Two Sigma Investments
46
Two Sigma Investments
New York
$630K +$735K +14,672 New
Deutsche Bank
47
Deutsche Bank
Germany
$629K +$668K +13,326 +986%
NA
48
Navellier & Associates
Nevada
$494K -$127K -2,532 -18%
ACM
49
Ativo Capital Management
Illinois
$489K +$35.1K +700 +7%
AA
50
ALPS Advisors
Colorado
$404K – – –
1
2
3 4 5

BSTC Hedge Fund Activity: Q4 2015 in Review

95 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2015, worth a combined $177M — up 20% from $148M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BSTC positions and 7 closed out — a net gain of 10 holders — while 37 added to existing stakes and 23 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $3.04M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $2.42M sold.

  • 95 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2015, up from 86 in Q3 2015.
  • Funds reported $177M of BioSpecifics Technologies Corp. stock for Q4 2015, up 20% quarter-over-quarter.
  • 17 funds opened new BioSpecifics Technologies Corp. positions in Q4 2015 and 7 closed out, a net change of +10 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2015 was Renaissance Technologies, an estimated $3.04M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2015 was Bogle Investment Management, an estimated $2.42M sold.

Based on aggregated 13F filings for Q4 2015.